HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME Test (opens in a new window) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kawamoto, S. Articles by Solomon, S. B. Search for Related Content PubMed PubMed Citation Articles by Kawamoto, S. Articles by Solomon, S. B. Related Collections Genitourinary Radiology Vascular and/or Interventional Radiology Oncologic Imaging

Sequential Changes after Radiofrequency Ablation and Cryoablation of Renal Neoplasms: Role of CT and MR Imaging¹

¹ From the Russell H. Morgan Department of Radiology and Radiological Science (S.K., D.A.B., E.K.F., S.B.S.) and the James Buchanan Brady Urological Institute (S.P., S.B.S.), Johns Hopkins Hospital, JHOC 3235A, 601 N Caroline St, Baltimore, MD 21287. Presented as an education exhibit at the 2005 RSNA Annual Meeting. Received June 13, 2006; revision requested July 24 and received August 30; accepted August 31. S.B.S. received grant support from Endocare; all remaining authors have no financial relationships to disclose. Address correspondence to S.K. (e-mail: skawamo1{at}jhmi.edu).

Radiofrequency (RF) ablation and cryoablation are increasingly being used as minimally invasive treatments for renal malignancies. Accurate assessment of ablated tumors at postprocedural imaging is essential for evaluating the adequacy of treatment and guiding further management. Renal tumors treated with RF ablation or cryoablation appear as low-attenuation regions at computed tomography (CT) and, relative to renal parenchyma, are generally hypointense at T2-weighted magnetic resonance (MR) imaging and iso- to hyperintense at T1-weighted imaging. The use of intravenous contrast material is essential for the evaluation of possible residual or recurrent tumor. At follow-up CT or MR imaging, successfully treated renal tumors appear as focal masses that demonstrate no evidence of contrast enhancement and that frequently decrease in size over time, whereas residual or recurrent tumor can be detected as abnormal foci of contrast enhancement. Follow-up surveillance imaging is warranted because long-term results for renal tumor ablation are not known, and evaluation for residual, recurrent, or metachronous tumor is essential.

© RSNA, 2007